Announcements Trials
Browse Landscape

Phase

Phase 2/3 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1Head & Neck 1Gynecologic 1Genitourinary 1Gastrointestinal 1Dermatologic 1Breast 1

Conditions

Uterine Cervical Neoplasms 1Pancreatic Neoplasms 1Ovarian Neoplasms 1Melanoma 1Lung Neoplasms 1Kidney Neoplasms 1Head and Neck Neoplasms 1Colonic Neoplasms 1Carcinoma, Hepatocellular 1Breast Neoplasms 1

Interventions

Cisplatin 17Radiotherapy 8pembrolizumab 7Radiotherapy, Intensity-Modulated 7Fluorouracil 7Magnetic Resonance Spectroscopy 6Docetaxel 6Platinum 5Gemcitabine 51,2-diaminocyclohexaneplatinum II citrate 5Paclitaxel 4Specimen Handling 3Radiation 3Drug Therapy 3Cetuximab 3Carboplatin 3(225)Ac-DOTA-c(RGDyK) 3atezolizumab 2Iodine-123 2Immunoglobulin G 2Fluorodeoxyglucose F18 2Disulfides 2Biopsy 2trametinib 1toripalimab 1ponatinib 1pertuzumab 1nimotuzumab 1fosbretabulin 1fluorocholine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 2/3 × cyclopropapyrroloindole × Head & Neck × Clear all
NCT03755739 2024-06-25

Trans-Artery/Intra-Tumor Infusion of Checkpoint Inhibitors Plus Chemodrug for Immunotherapy of Advanced Solid Tumors

Second Affiliated Hospital of Guangzhou Medical University

Phase 2/3 Recruiting
200 enrolled
BreastDermatologicGastrointestinalGenitourinaryGynecologicHead & NeckThoracic

Breast Neoplasms, Uterine Cervical Neoplasms, Colonic Neoplasms, Head and Neck Neoplasms, Carcinoma, Hepatocellular, Kidney Neoplasms, Lung Neoplasms, Melanoma, Ovarian Neoplasms, Pancreatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡